Form 4 for IMVT Immunovant, Inc.
Accepted 2026-05-29 16:04:59 ET · period of report 2026-05-28 · accession 0001341896-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-29 16:04 | 2026-05-28 | IMVT | Fromkin Andrew J. | Dir | M - OptEx | $8.22 | +196.6K | 296.3K | +197% | +$1.62M |
| DM | 2026-05-29 16:04 | 2026-05-28 | IMVT | Fromkin Andrew J. | Dir | S - Sale+OE | $33.51 | -222.0K | 74.4K | -75% | -$7.44M |
| DM | 2026-05-29 16:04 | 2026-05-28 | IMVT | Fromkin Andrew J. | Dir | M - OptEx | $0.00 | -196.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-28 | M | A | 31,668 | $4.99 | 131,400 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-28 | M | A | 71,492 | $7.94 | 202,892 | D | — | — | |
| 3 | Common | Common Stock | 2026-05-28 | M | A | 77,181 | $8.43 | 280,073 | D | — | — | |
| 4 | Common | Common Stock | 2026-05-28 | M | A | 16,260 | $14.70 | 296,333 | D | — | — | |
| 5 | Common | Common Stock | 2026-05-28 | S | D | 11,483 | $32.64 | 284,850 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.04 - $33.035 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 6 | Common | Common Stock | 2026-05-28 | S | D | 210,468 | $33.56 | 74,382 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.04 - $33.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 7 | Derivative | Stock Option (right to buy) | 2026-05-28 | M | D | 31,668 | $0.00 | 0 | D | $4.99 · — to 2032-08-17 | 31,668 Common Stock | (F3) Reflects an award of stock options to purchase Common Shares that is fully vested. |
| 8 | Derivative | Stock Option (right to buy) | 2026-05-28 | M | D | 71,492 | $0.00 | 0 | D | $7.94 · — to 2032-01-10 | 71,492 Common Stock | (F3) Reflects an award of stock options to purchase Common Shares that is fully vested. |
| 9 | Derivative | Stock Option (right to buy) | 2026-05-28 | M | D | 77,181 | $0.00 | 0 | D | $8.43 · — to 2029-11-19 | 77,181 Common Stock | (F3) Reflects an award of stock options to purchase Common Shares that is fully vested. |
| 10 | Derivative | Stock Option (right to buy) | 2026-05-28 | M | D | 16,260 | $0.00 | 0 | D | $14.70 · — to 2033-04-12 | 16,260 Common Stock | (F3) Reflects an award of stock options to purchase Common Shares that is fully vested. |